These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 172392)

  • 1. Cyclic nucleotide phosphodiesterases in uterine development.
    Stancel GM; Thompson WJ; Strada SJ
    Mol Cell Endocrinol; 1975 Oct; 3(4):283-95. PubMed ID: 172392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of soluble uterine cyclic nucleotide phosphodiesterase.
    Gardner EA; Thompson WJ; Strada SJ; Stancel GM
    Biochemistry; 1978 Jul; 17(15):2995-3000. PubMed ID: 212098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclic nucleotide phosphodiesterases from rat anterior pituitary. Characterization of multiple forms and regulation by protein activator and Ca+.
    Azhar S; Menon KM
    Eur J Biochem; 1977 Feb; 73(1):73-82. PubMed ID: 190011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for convertible forms of soluble uterine cyclic nucleotide phosphodiesterase.
    Strada SJ; Epstein PM; Gardner EA; Thompson WJ; Stancel GM
    Biochim Biophys Acta; 1981 Sep; 661(1):12-20. PubMed ID: 6271215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclid 3':5'-nucleotide phosphodiesterase. Interconvertible multiple forms and their effects on enzyme activity and kinetics.
    Pichard AL; Cheung WY
    J Biol Chem; 1976 Sep; 251(18):5726-37. PubMed ID: 184086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 3':5'-cyclic-nucleotide phosphodiesterases of mammalian sera.
    Asano T; Hidaka H
    Biochim Biophys Acta; 1975 Jul; 397(1):124-33. PubMed ID: 238629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human thyroid cyclic nucleotide phosphodiesterase. Its characterization and the effect of several hormones on the activity.
    Nagasaka A; Hidaka H
    Biochim Biophys Acta; 1976 Jul; 438(2):449-60. PubMed ID: 182233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of phosphodiesterases III and IV in the modulation of vascular cyclic AMP content by the NO/cyclic GMP pathway.
    Eckly AE; Lugnier C
    Br J Pharmacol; 1994 Oct; 113(2):445-50. PubMed ID: 7834194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dissimilar cyclic nucleotide phosphodiesterase activities in subcellular fractions from normal and SV40-transformed WI-38 fibroblasts.
    Nemecek GM; Butcher RW
    J Cyclic Nucleotide Res; 1979 Dec; 5(6):449-61. PubMed ID: 94064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hydrolysis of N-methyl-D-aspartate receptor-stimulated cAMP and cGMP by PDE4 and PDE2 phosphodiesterases in primary neuronal cultures of rat cerebral cortex and hippocampus.
    Suvarna NU; O'Donnell JM
    J Pharmacol Exp Ther; 2002 Jul; 302(1):249-56. PubMed ID: 12065724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Properties of the activator-dependent cyclic nucleotide phosphodiesterase from bovine heart.
    Donnelly TE
    Biochim Biophys Acta; 1977 Jan; 480(1):194-203. PubMed ID: 188479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in phosphodiesterase activity in the developing rat submandibular gland.
    Tanaka S; Shimooka S; Shimomura H
    Arch Oral Biol; 2002 Aug; 47(8):567-76. PubMed ID: 12221013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclic nucleotide-mediated regulation of vascular smooth muscle cell cyclic nucleotide phosphodiesterase activity. Selective effect of cyclic AMP.
    Maurice DH
    Cell Biochem Biophys; 1998; 29(1-2):35-47. PubMed ID: 9631237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of mammalian cyclic AMP phosphodiesterases by trypsin.
    Epstein PM; Pledger WJ; Gardner EA; Stancel GM; Thompson WJ; Strada SJ
    Biochim Biophys Acta; 1978 Dec; 527(2):442-55. PubMed ID: 215213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Opposite regulation of cAMP concentration in the quail oviduct and the mouse uterus by tamoxifen. Correlation with estrogen-antagonist and estrogen-agonist activity.
    Fanidi A; Ahnadi C; Fayard JM; Pageaux JF; Laugier C
    J Steroid Biochem Mol Biol; 1992 Mar; 41(3-8):571-7. PubMed ID: 1314079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. "cAMP-specific" phosphodiesterase contributes to cGMP degradation in cerebellar cells exposed to nitric oxide.
    Bellamy TC; Garthwaite J
    Mol Pharmacol; 2001 Jan; 59(1):54-61. PubMed ID: 11125024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sequential alterations in the hepatic content and metabolism of cyclic AMP and cyclic GMP induced by DL-ethionine: evidence for malignant transformation of liver with a sustained increase in cyclic AMP.
    DeRubertis FR; Craven PA
    Metabolism; 1976 Dec; 25(12):1611-25. PubMed ID: 186692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclic nucleotide phosphodiesterase in silkworm. Developmental change of cyclic AMP and cyclic GMP phosphodiesterases.
    Morishima I
    Biochim Biophys Acta; 1975 Sep; 403(1):106-12. PubMed ID: 240422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of cyclic nucleotide phosphodiesterase activity in myometrium from pregnant and spayed rhesus monkeys.
    Beatty CH; Bocek RM; Herrington PT
    J Reprod Fertil; 1979 Mar; 55(2):391-400. PubMed ID: 220417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Properties of multiple kinetic forms of soluble cyclic nucleotide phosphodiesterase activity of rat colonic mucosa.
    Craven PA; Neidig M; DeRubertis FR
    Biochim Biophys Acta; 1983 May; 744(3):265-75. PubMed ID: 6303428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.